Active — Not RecruitingNot Applicable

Nicotine Replacement Therapy Prescribing and Lung Cancer Screening in Hospitalized Patients

United States220 participantsStarted 2025-11-17

Plain-language summary

Investigators are evaluating an EHR-based, non-interruptive alert to increase NRT prescribing in the hospital and at discharge for hospitalized patients. Investigators will investigate two randomized groups of resident physicians to evaluate their prescribing behaviors when the tool is introduced.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Patients Inclusion Criteria: * Hospitalized patients admitted to a General Medicine Service at MUSC Charleston * Identified as actively smoking tobacco via nursing admission screening * Admitted by a resident physician participating in the study (as indicated by the H\&P note) Exclusion Criteria: • None Resident Physicians: Inclusion Criteria: • Internal medicine resident physicians rotating on the hospitalist service at MUSC Health Charleston Exclusion Criteria: • None

What they're measuring

Nicotine Replacement Therapy (NRT) prescribing rates during hospitalization

Timeframe: During hospitalization, assessed from admission to discharge (average of 3-7 days)

Nicotine Replacement Therapy (NRT) prescribing rates at discharge

Timeframe: During hospitalization, assessed from admission to discharge (average of 3-7 days)

Rate of referral to outpatient tobacco cessation clinic

Timeframe: During hospitalization, assessed from admission to discharge (average of 3-7 days)

Trial details

NCT IDNCT07164404

SponsorMedical University of South Carolina

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09

View on ClinicalTrials.gov More Tobacco Use Disorder trials